Veronica Chiang

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Paul W. Sperduto, Norbert Kased, David Roberge et al. · Journal of Clinical Oncology · 2011 · 1.4K citations · Full text

Medicine, Oncology, Diagnostic Assessment +10

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Scott Gettinger, Amit Mahajan et al. · The Lancet Oncology · 2016 · 996 citations · Full text

Medicine, Oncology, Pharmacology +16

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Paul W. Sperduto, Samuel T. Chao, Penny K. Sneed et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 985 citations

Medicine, Biostatistics, Oncology +17

Estimating Survival in Patients With Lung Cancer and Brain Metastases

Paul W. Sperduto, Jonathan T. Yang, Kathryn Beal et al. · JAMA Oncology · 2016 · 658 citations · Full text

Medicine, Biostatistics, Oncology +17

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger et al. · The Lancet Oncology · 2020 · 538 citations · Full text

Medicine, Oncology, Pharmacotherapy +16